Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial

INTRODUCTION: The optimal haemodialysis (HD) prescription—frequency and dose—for patients with incident dialysis-dependent kidney disease (DDKD) and substantial residual kidney function (RKF)—that is, renal urea clearance ≥2 mL/min/1.73 m(2) and urine volume ≥500 mL/day—is not known. The aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Murea, Mariana, Moossavi, Shahriar, Fletcher, Alison J, Jones, Deanna N, Sheikh, Hiba I, Russell, Gregory, Kalantar-Zadeh, Kamyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149445/
https://www.ncbi.nlm.nih.gov/pubmed/34031117
http://dx.doi.org/10.1136/bmjopen-2020-047596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149445/
https://www.ncbi.nlm.nih.gov/pubmed/34031117
http://dx.doi.org/10.1136/bmjopen-2020-047596

Ejemplares similares